Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoCal Diabetes appears to be a Southern California diabetes-focused clinical practice rather than a biotech or pharmaceutical developer. Public web listings describe it as a medical clinic/endocrinology or diabetes care provider with locations in Newport Beach and Torrance, California, and a listed phone number of 310-962-1808. Available evidence suggests the organization provides patient-facing diabetes diagnosis, management, and related endocrine care services, not a drug-development pipeline. There is no clear evidence from accessible public sources that it operates proprietary therapeutics, a research platform, or a clinical-stage product portfolio. As a result, it is best categorized as a healthcare services provider in diabetes care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SoCal Diabetes.